). The Band 3-Memphis variant has a point mutation (166A>G) in the SLC4A1 gene, which encodes the amino acid substitution Lys56Glu. Two types of Band 3-Memphis, variants I and II, are distinguished by their susceptibility to covalent labelling with 4,4′-diisothiocyanato-1,2-diphenylethane-2,2′-disulphonic acid (H 2 DIDS). Memphis II is more readily labelled than Memphis I or normal band 3. It is reported that Memphis II is associated with Di a . In a study designed to determine the frequency of the DI *A/DI *B and 166A>G polymorphisms in different populations in Brazil, we found a new DI *A allele.
Introduction
The Diego blood-group system consists of 21 antigens carried on band 3: it comprises two pairs of anti-thetical antigensDi AE1) have revealed the molecular bases associated with these antigens [2] [3] [4] [5] [6] [7] . In the erythrocyte membrane, band 3 is the major protein and transports anions and anchors the erythrocyte lipid bilayer to the membrane skeleton [8] [9] [10] . The N-terminal 40 000-molecular weight (MW) domain binds glycolytic enzymes and haemoglobin, and the glycosylated C-terminal transmembrane 55-MW domain carries out anion transport [11] . Band 3-Memphis is a variant of band 3 characterized by slower migration than the normal band 3 on sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) after treatment of red blood cells (RBCs) with pronase or α-chymotrypsin. Band 3-Memphis results from a point mutation -166A>G -in the SLC4A1, leading to an amino acid substitution, Lys56Glu, in the cytoplasmic domain [12, 13] . There are two types of Band 3-Memphis, variants I and II, which are distinguished by their susceptibility to covalent labelling with 4,4′-diisothiocyanato-1,2-diphenylethane-2,2′-disulphonic acid (H 2 DIDS). Band 3-Memphis II is more readily labelled than Band 3-Memphis I or normal band 3 [14] . Spring et al. [15] African Blacks and is common among South Americans (up to 54%) and southeast Asians (12%) [17] . The frequency of Band 3-Memphis varies among different populations; it is relatively common in Native Americans (up to 25%), African Americans (15%) and Japanese (29%) [17] [18] [19] [20] . Prior to the study described here, SLC4A1 analysis performed on DNA from people whose RBCs express the Di a antigen showed 2561T; 854Leu together with the Band 3-Memphis polymorphism 166G; 56Glu [15, 16] . This finding, in conjunction with electrophoretic and serological studies, led to the assumption that DI*A was linked with the Band 3-Memphis mutation. In this study, we report the allelic frequencies of DI*A and DI*B, and their degree of association with Band 3-Memphis, among Brazilians, a population characterized by intense racial admixture. These polymorphisms were analysed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) performed on DNA samples from Amazonian Indians, Japanese living in Sao Paulo, Brazilian blood donors, and African Brazilians with sickle cell disease (SCD). During this study, we identified a novel allele with DI*A, but without the expected 166G mutation (Band 3-Memphis), in four of 70 Amazonian Indians.
Subjects and methods

Population studied
Peripheral blood samples from 318 people were collected in EDTA after obtaining signed informed consent, as approved by the Institutional Review Board. The samples were from four ethnic groups: 70 Amazonian Indians (from Parakanã tribe), 71 individuals of Japanese descent (representing a racial mixture between Japanese and South American descendents), 93 random Brazilian blood donors (representing a high inter-racial mixture among Europeans, South Americans and African Americans), and 84 African Brazilians (representing admixture with native Brazilians) with SCD.
The Parakanã Indians
The Parakanã Indians belong to the Tupi group, and did not have contact with other populations until 1971. The tribe is small and resides in three villages in the State of Pará (Northern Brazil). This population has a restricted range of polymorphisms for several genetic markers, including blood groups [21] . 
Haemagglutination
DNA preparation and PCR amplification
DNA was extracted from leucocytes by using either the phenol-chloroform method [22] or DNAzol (Gibco BRL®, Gaithersburg, MD), according to the manufacturer's recommendations. PCR assays were designed to amplify a segment of 149 bp from exon 19 of SLC4A1 for the identification of DI*A/DI*B alleles, and a segment of 84 bp from exon 4 of SLC4A1 for the detection of Band 3-Memphis. The primers used to determine DI*A/DI*B alleles were DiEX19S: 5′-TGGCGCATGCACTTATTCAC-3′ (sense) and DiEX19R: 5′-TTCCTGAAGATGAGCGGCAG-3′ (antisense). The primers to determine the presence of 166G (band 3-Memphis) were DiEX4S: 5′-TTCAGCTCACGACACCGAGG-3′ (sense) and DiI4AS: 5′-GAGGCTGGGGTCCTCACCTT-3′ (antisense). Primer sequences were designed based on the GenBank accession number X77738. PCR amplification was carried out in a thermal cycler (model 9700; Perkin Elmer, Foster City, CA), using 100-200 ng of DNA, 50 pmol of each primer, 2 nmol of each dNTP, 2·0 mM MgCl 2 , 1·0 U Taq DNA polymerase, and buffer in a final volume of 50 µl. The PCR profile used in all assays was as follows: 15 min at 95 °C; 35 cycles of 40 seconds at 94 °C, 40 seconds at 62 °C, and 1 min at 72 °C; followed by 10 min at 72 °C.
RFLP analysis
After amplification, 10 µl of PCR product was digested overnight with the appropriate restriction enzyme. MspI (MBI Fermentas, Amherst, NY) was used to study the 2561C>T mutation in exon 19 associated with DI polymorphism, and MnlI (MBI Fermentas) was used to study the 166A>G mutation (Band 3-Memphis) in exon 4. Restriction enzyme digestion was performed in a final volume of 20 µl under conditions recommended by, and using buffers provided by, the manufacturer. RFLP bands were analysed after electrophoresis in 2% agarose in Tris-acetate-EDTA buffer.
Sequence analysis
DNA from four Amazonian Indian samples that apparently had a DI*A allele without the expected 166G, as judged by PCR-RFLP analysis, were cloned and sequenced. PCR products amplified from genomic DNA using the primers for exon 4 (DiEX4S/DiI4AS) and exon 19 (DiEX19S/DiEX19) (as described above) were purified by elution from 1% agarose gels using a Qiaex II gel-extraction kit (Qiagen, Valencia, CA), and cloned into a TA vector (Invitrogen, Carlsbad, CA). Sequencing was performed on an ABI 373XL Perkin Elmer Biosystems (PEB) sequencer, and the PEB Big Dye reagent BD Half-term (GenPak, Perkin Elmer).
Results
Distribution of DI*A/DI*B alleles and correlation with the Diego phenotype
The DI*A/DI*B PCR-MspI-RFLP and antigen-typing results obtained on the 318 samples were in complete agreement and are shown in Table 1 . These results are consistent with published prevalence data obtained from serological studies [17] . 
Correlation between the DI*A and DI*B alleles with Band 3-Memphis
Analysis of novel allele
Distribution of allelic frequencies according to ethnic group
The allelic frequencies are shown in Table 2 . Both the DI*A allele and the Band 3-Memphis 166 allele were frequent in Amazonian Indians (allelic frequencies of 0·57 and 0·54, respectively). The DI*A allele was less frequent in the other ethnic groups: 0·07 in Japanese, 0·02 in Brazilian blood donors, and 0·01 in the African Brazilians with SCD. Band 3-Memphis was present in 0·19 of Japanese, 0·04 of general blood donors, and 0·09 of African Brazilians with SCD.
Conclusion
We report the frequencies of DI*A and DI*B alleles, in relation to the Band 3-Memphis polymorphism, in different populations in Brazil. During this population study, unexpectedly we found four Amazonian Indians who had the DI*A allele associated with 166A instead of the expected 166G that defines the Band 3-Memphis variant (Fig. 1) [15, 16] . Red cells from these four people typed Di(a+b-). The high frequency of 166G in the DI*A allele in Amazonian Indians is consistent with published data [20] . In contrast to the other populations, among the Amazonian Indians none of the 60 DI *B alleles had the 166G mutation, whereas 76 of the 80 DI *A alleles had the 166G mutation. Among the 71 Japanese included in this study (142 alleles), 10 were DI*A and 132 were DI*B; 27 were 166G. We observed a correlation between DI A and 166G, and the presence of 166G with some of the DI*B alleles, which is consistent with the findings of Spring et al. [15] and Black et al. [21] Our findings highlight the importance of analysing different populations to achieve a better understanding of the genetic basis associated with blood-group antigens. Blood donors  0·02  0·98  0·96  0·04  SCD patients  0·01  0·99  0·91  0·09  Japanese  0·07  0·93  0·81  0·19  Amazonian Indians  0·57  0·43  0·46  0·54 SCD, sickle cell disease. 
